Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Jacobson Pharma Corporation Limited ( (HK:2633) ) just unveiled an update.
Jacobson Pharma Corporation Limited has announced that its board of directors will meet on November 18, 2025, to review and approve the interim results for the six months ending September 30, 2025. The meeting will also consider the payment of an interim dividend and address other business matters, which could impact the company’s financial strategy and stakeholder interests.
The most recent analyst rating on (HK:2633) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Jacobson Pharma Corporation Limited stock, see the HK:2633 Stock Forecast page.
More about Jacobson Pharma Corporation Limited
Jacobson Pharma Corporation Limited is a pharmaceutical company incorporated in the Cayman Islands. It operates in the healthcare industry, focusing on the development, production, and distribution of pharmaceutical products.
Average Trading Volume: 633,384
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.77B
For a thorough assessment of 2633 stock, go to TipRanks’ Stock Analysis page.